Logo image of REAX

REAL BROKERAGE INC/THE (REAX) Stock Fundamental Analysis

NASDAQ:REAX - Nasdaq - CA75585H2063 - Common Stock - Currency: USD

4.12  -0.14 (-3.29%)

After market: 4.12 0 (0%)

Fundamental Rating

4

Taking everything into account, REAX scores 4 out of 10 in our fundamental rating. REAX was compared to 65 industry peers in the Real Estate Management & Development industry. REAX has a great financial health rating, but its profitability evaluates not so good. REAX is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year REAX has reported negative net income.
REAX had a positive operating cash flow in the past year.
REAX had negative earnings in each of the past 5 years.
REAX had a positive operating cash flow in 4 of the past 5 years.
REAX Yearly Net Income VS EBIT VS OCF VS FCFREAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

REAX has a worse Return On Assets (-15.34%) than 69.23% of its industry peers.
REAX has a worse Return On Equity (-47.05%) than 64.62% of its industry peers.
Industry RankSector Rank
ROA -15.34%
ROE -47.05%
ROIC N/A
ROA(3y)-40.11%
ROA(5y)-33.2%
ROE(3y)-83.38%
ROE(5y)-70.74%
ROIC(3y)N/A
ROIC(5y)N/A
REAX Yearly ROA, ROE, ROICREAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

REAX's Gross Margin of 9.02% is on the low side compared to the rest of the industry. REAX is outperformed by 67.69% of its industry peers.
In the last couple of years the Gross Margin of REAX has declined.
REAX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 9.02%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
REAX Yearly Profit, Operating, Gross MarginsREAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

7

2. Health

2.1 Basic Checks

REAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
REAX has more shares outstanding than it did 1 year ago.
REAX has more shares outstanding than it did 5 years ago.
REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
REAX Yearly Shares OutstandingREAX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
REAX Yearly Total Debt VS Total AssetsREAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 20.08 indicates that REAX is not in any danger for bankruptcy at the moment.
REAX's Altman-Z score of 20.08 is amongst the best of the industry. REAX outperforms 95.38% of its industry peers.
REAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 20.08
ROIC/WACCN/A
WACC9.12%
REAX Yearly LT Debt VS Equity VS FCFREAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

A Current Ratio of 1.23 indicates that REAX should not have too much problems paying its short term obligations.
REAX has a Current ratio (1.23) which is comparable to the rest of the industry.
REAX has a Quick Ratio of 1.23. This is a normal value and indicates that REAX is financially healthy and should not expect problems in meeting its short term obligations.
REAX's Quick ratio of 1.23 is in line compared to the rest of the industry. REAX outperforms 50.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
REAX Yearly Current Assets VS Current LiabilitesREAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

REAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 65.00%, which is quite impressive.
The Revenue has grown by 81.31% in the past year. This is a very strong growth!
REAX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 140.25% yearly.
EPS 1Y (TTM)65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.78%
Revenue 1Y (TTM)81.31%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%76.34%

3.2 Future

Based on estimates for the next years, REAX will show a very strong growth in Earnings Per Share. The EPS will grow by 42.06% on average per year.
Based on estimates for the next years, REAX will show a very strong growth in Revenue. The Revenue will grow by 29.87% on average per year.
EPS Next Y47.18%
EPS Next 2Y42.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year46.28%
Revenue Next 2Y29.87%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
REAX Yearly Revenue VS EstimatesREAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
REAX Yearly EPS VS EstimatesREAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 -0.05 -0.1 -0.15

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

REAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
REAX is valuated quite expensively with a Price/Forward Earnings ratio of 1615.69.
Based on the Price/Forward Earnings ratio, REAX is valued a bit cheaper than the industry average as 64.62% of the companies are valued more expensively.
REAX is valuated expensively when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 1615.69
REAX Price Earnings VS Forward Price EarningsREAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 500 1K 1.5K

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, REAX is valued cheaper than 81.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 20.24
EV/EBITDA N/A
REAX Per share dataREAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates REAX does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as REAX's earnings are expected to grow with 42.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.06%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

REAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REAL BROKERAGE INC/THE

NASDAQ:REAX (6/5/2025, 4:30:02 PM)

After market: 4.12 0 (0%)

4.12

-0.14 (-3.29%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-08 2025-05-08/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners45.44%
Inst Owner Change4.75%
Ins Owners13.08%
Ins Owner ChangeN/A
Market Cap849.54M
Analysts86
Price Target6.8 (65.05%)
Short Float %2%
Short Ratio3.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)45.53%
Min EPS beat(2)34.64%
Max EPS beat(2)56.43%
EPS beat(4)4
Avg EPS beat(4)52.34%
Min EPS beat(4)34.64%
Max EPS beat(4)67.32%
EPS beat(8)6
Avg EPS beat(8)11.17%
EPS beat(12)8
Avg EPS beat(12)8.1%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.39%
Min Revenue beat(2)4.24%
Max Revenue beat(2)14.54%
Revenue beat(4)4
Avg Revenue beat(4)12.6%
Min Revenue beat(4)4.24%
Max Revenue beat(4)26.33%
Revenue beat(8)8
Avg Revenue beat(8)16.57%
Revenue beat(12)12
Avg Revenue beat(12)19.55%
Revenue beat(16)15
Avg Revenue beat(16)20.62%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)200%
EPS NQ rev (3m)250.15%
EPS NY rev (1m)-3.57%
EPS NY rev (3m)-3.57%
Revenue NQ rev (1m)2.79%
Revenue NQ rev (3m)10.1%
Revenue NY rev (1m)3.37%
Revenue NY rev (3m)12.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1615.69
P/S 0.6
P/FCF 20.24
P/OCF 19.66
P/B 25.94
P/tB 39.69
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)0
Fwd EY0.06%
FCF(TTM)0.2
FCFY4.94%
OCF(TTM)0.21
OCFY5.09%
SpS6.88
BVpS0.16
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.34%
ROE -47.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 9.02%
FCFM 2.96%
ROA(3y)-40.11%
ROA(5y)-33.2%
ROE(3y)-83.38%
ROE(5y)-70.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.17%
GM growth 5Y-6.44%
F-Score7
Asset Turnover14.11
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 85.16%
Cap/Sales 0.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z 20.08
F-Score7
WACC9.12%
ROIC/WACCN/A
Cap/Depr(3y)185.96%
Cap/Depr(5y)132.21%
Cap/Sales(3y)0.18%
Cap/Sales(5y)0.16%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.78%
EPS Next Y47.18%
EPS Next 2Y42.06%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)81.31%
Revenue growth 3Y118.22%
Revenue growth 5Y140.25%
Sales Q2Q%76.34%
Revenue Next Year46.28%
Revenue Next 2Y29.87%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y57.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year305.8%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2085.78%
FCF growth 3Y133%
FCF growth 5YN/A
OCF growth 1Y1298.09%
OCF growth 3Y131.26%
OCF growth 5YN/A